NCT05127785

Brief Summary

To investigate how measures of frailty, assessed during occupational therapy (OT) evaluation and intervention impact decision for advanced heart failure (HF) therapies and postoperative outcomes.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 9, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 19, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

November 9, 2021

Last Update Submit

May 28, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Hospital Length of Stay

    Length of hospital stay after intervention

    1 to 500 days

  • Rate of Readmission

    Rate of Readmission after initial hospital discharge

    30 to 90 days

Study Arms (3)

Medical Management

Patients deemed not candidates for advanced heart failure interventions.

Left Ventricular Assist Device (LVAD)

Recipients of a left ventricular assist device

Procedure: LVAD or Heart Transplant

Heart Transplant

Recipients of a heart transplant.

Procedure: LVAD or Heart Transplant

Interventions

Patients undergoing advanced heart failure intervention including LVAD implantation or heart transplantation

Heart TransplantLeft Ventricular Assist Device (LVAD)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with heart failure undergoing evaluation for advanced heart failure therapy.

You may qualify if:

  • Individuals will be included in this study if they were evaluated for advanced heart failure therapies at Keck Hospital from 1/1/2019-6/30/2021. This will be determined through data from the electronic medical record.

You may not qualify if:

  • Patients who did not receive an occupational therapy evaluation prior to advanced heart failure intervention decision.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keck Hospital of USC

Los Angeles, California, 90077, United States

Location

MeSH Terms

Conditions

Heart FailureFrailty

Interventions

Heart Transplantation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical ProceduresOrgan TransplantationTransplantation

Study Officials

  • Elyse Peterson, OTD, OTR/L

    University of Southern California

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Clinical Occupational Therapy

Study Record Dates

First Submitted

November 9, 2021

First Posted

November 19, 2021

Study Start

November 9, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2023

Last Updated

May 30, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations